Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence

BACKGROUND: The role of sorafenib in patients with hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been rarely studied. The aim of this study was to evaluate the efficacy of sorafenib in post-LT era. METHODS: Consecutive patients with post-transplant HCC recurrence not...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Korean Med Sci
Autori principali: Kang, Seong Hee, Cho, Hyeki, Cho, Eun Ju, Lee, Jeong-Hoon, Yu, Su Jong, Kim, Yoon Jun, Yi, Nam-Joon, Lee, Kwang-Woong, Suh, Kyung-Suk, Yoon, Jung-Hwan
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Korean Academy of Medical Sciences 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6209769/
https://ncbi.nlm.nih.gov/pubmed/30402048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2018.33.e283
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi